Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
FAA allows pilots to undergo CK treatment
Irvine, CA—The Federal Aviation Administration is allowing pilots to have the conductive keratoplasty (NearVision CK, Refractec Inc.) treatment to reduce their dependence on glasses.
Irvine, CA-The Federal Aviation Administration is allowing pilots to have the conductive keratoplasty (NearVision CK, Refractec Inc.) treatment to reduce their dependence on glasses.
The procedure uses radiofrequency energy to reshape the cornea.
"Certification by the FAA as a vision correction procedure for pilots validates the safety and value of CK as a refractive treatment," said Mitchell B. Campbell, president of Refractec.
Related Videos
Related Content
